OppenheimerFunds’s Dentsply Sirona XRAY Stock Holding History

OppenheimerFunds’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$354K	Sell	7,145 -1,798	-20%	-$79.2K	﹤0.01%	1495
2018 Q4	$333K	Sell	8,943 -489	-5%	-$17.8K	﹤0.01%	1530
2018 Q3	$356K	Buy	9,432 +1,435	+18%	+$59.8K	﹤0.01%	1579
2018 Q2	$350K	Buy	7,997 +1,697	+27%	+$79.7K	﹤0.01%	1558
2018 Q1	$317K	Sell	6,300 -2,628	-29%	-$155K	﹤0.01%	1570
2017 Q4	$588K	Buy	8,928 +14	+0.2%	+$890	﹤0.01%	1432
2017 Q3	$533K	Buy	8,914 +906	+11%	+$53.9K	﹤0.01%	1493
2017 Q2	$519K	Buy	8,008 +705	+10%	+$44.5K	﹤0.01%	1483
2017 Q1	$456K	Sell	7,303 -777,237	-99%	-$46.8M	﹤0.01%	1530
2016 Q4	$45.3M	Sell	784,540 -681,885	-46%	-$40.3M	0.06%	342
2016 Q3	$87.1M	Sell	1,466,425 -41,180	-3%	-$2.53M	0.11%	219
2016 Q2	$93.5M	Buy	1,507,605 +314,578	+26%	+$19.4M	0.12%	201
2016 Q1	$73.5M	Buy	1,193,027 +1,189,156	+30,720%	+$70.1M	0.1%	235
2015 Q4	$237K	Buy	+3,871	New	+$230K	﹤0.01%	1606

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OppenheimerFunds's XRAY Position: Q1 2019 in Review

OppenheimerFunds reduced its Dentsply Sirona (XRAY) stake by 20% in Q1 2019, selling an estimated $79.2K and leaving 7,145 shares worth $354K. The position accounts for ﹤0.01% of the portfolio, ranked #1495.

OppenheimerFunds first reported a position in XRAY in Q4 2015 and has held it in 14 quarters since. The position peaked at $93.5M in Q2 2016. 531 funds tracked by Wall St. Rank hold XRAY as of Q1 2019.

OppenheimerFunds held 7,145 shares of Dentsply Sirona worth $354K as of Q1 2019.
OppenheimerFunds sold 1,798 Dentsply Sirona shares in Q1 2019, an estimated $79.2K.
Dentsply Sirona made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1495 holding.
OppenheimerFunds first reported a position in Dentsply Sirona in Q4 2015 and has held it in 14 quarters since.
OppenheimerFunds's Dentsply Sirona position peaked at $93.5M in Q2 2016.
531 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.